MarkRobertFowlerMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Fowler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

University of North Carolina HospitalsFellowship, Cytopathology, 2021 - 2022
University of North Carolina HospitalsChief Residency, Pathology-Anatomic and Clinical, 2020 - 2021
University of North Carolina HospitalsResidency, Pathology-Anatomic and Clinical, 2017 - 2021
University of Texas Medical Branch School of MedicineClass of 2017

PubMed

1 citations
Effect of Proton Pump Inhibitor Treatment in "PPI Non-responsive" Patients with Eosinophilic Esophagitis.
Hamish Philpott, Sean Lafata, Mark Fowler, Staci Keene, Alina Iuga, E Dellon, Kisan P Thakkar> ;Journal of Gastrointestinal and Liver Diseases. 2023 Mar 31
5 citations
Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis.
Mark Fowler, Staci Keene, Alina Iuga, Evan S Dellon, Thakkar, K.> ;Digestive and Liver Disease. 2022 Sep 1
3 citations
Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis
Nicole C. Chang, Soha Raja, Renee Betancourt, Cara Randall, Staci Keene, Amy Lilly, Mark Fowler, John T. Woosley, Nicholas J. Shaheen, Evan S. Dellon> ;Digestive Diseases and Sciences. 2021 Jan 25
1 citations
PD-L1 Expression in Extramammary Paget Disease: A Case Series.
Mark Fowler, Kendall L Flanigan, Paul B. Googe> ;The American Journal of Dermatopathology. 2021 Jan 1
20 citations
Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.
Erin M. Kim, Cara Randall, Renee Betancourt, Staci Keene, Amy Lilly, Mark Fowler, Evan S. Dellon, Hans H Herfarth> ;Inflammatory Bowel Diseases. 2020 Jul 17
Join now to see all